维普中文期刊产品整合服务
50篇 您的检索式:作者名="Bergman AJ"
    题名 作者 年代 出处 被引量
1Sitagliptin(MK-0431), a se- lective dipeptidyl-peptidase 1V (DPP-4) inhibitor, does not affect the pharmacokinetics of simvastatin in humans显示文摘Bergman AJ Cote J Maes A 2005Clln Pharmacol Ther2005,79,1:1
2Pharmacokinetic and pharmacodynamic properties of multiple oral doses ofsitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers显示文摘Bergman AJ Stevens C Zhou Y 2006Clin Ther2006,28,1:1
3Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin a dipeptidyl peptidase-Ⅳ inhibitor:a double-blind,randomized,placebo-controlled study in healthy male volunteers显示文摘BERGMAN AJ STEVENS C ZHOU Y 2006Clin Ther2006,28,1:1
4Metabolism And Excretion of the Dipeptidyl Peptidase 4 Inhibitor Sita- gliptin in Human 显示文摘Vincent SH Reed JR' Bergman AJ 2007Drug netab Dispos2007,35,4:1
5Effect of mod- erate hepatic insufficiency on the pharmacokinetics of phar- macokinetics of sitagIiptin显示文摘Migoya EM Stevens CH Bergman AJ 2009Can J Clin Pharmacol2009,16,1:1
6Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib,a potent cholesteryl ester transfer protein (CETP) inhibitor,in healthy subjects显示文摘Krishna R Bergman AJ Jin B 2008Clin Pharmacol Ther2008,84,6:1
7Age-related changes in osteogenic stem cells in mice显示文摘Bergman RJ Gazit D Kahn AJ 0,,05:1
8Effect of the cholesteryl ester transfer protein inhibitor,anacetrapib,on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals:two double-blind,randomised placebo-controlled phase I studies显示文摘Krishna R Anderson MS Bergman AJ 2007Lancet2007,370,9603:1
9lnterobserver reliability of physical examination of shoulder girdle 显示文摘Nomden JG Slagers AJ Bergman GJ 2009Man Ther2009,14,2:1
10Age-related changes in osteogenic stem ceils in mice 显示文摘Bergman R J Gazit D Kahn AJ J Bone Miner Res0,11,5:1
11Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor显示文摘Bergman AJ Cote J Yi B 2007Diabetes Care2007,30,7:1
12Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin,a dipeptidyl peptidase-IV inhibitor: a double- blind, randomized, placebo-controlled study in healthy male volunteers 显示文摘Bergman AJ Stevens C Zhou Y 2006Clin Ther2006,28,1:1
13Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin,a dipeptidyl peptidase-Ⅳ inhibitor:a double-blind,randomized,placebo-controlled study in healthy male volunteers显示文摘BERGMAN AJ STEVENS C ZHOU Y 2006Clin Ther2006,28,1:1
14Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers显示文摘Bergman AJ Stevens C Zhou Y 2006Clin Yher2006,28,:1
15Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin 显示文摘Migoya EM Stevens CH Bergman AJ 2009Can J Clin Pharmacol2009,16,1:1
16Metabolism and excretion of the DPP-4 inhibitor sitagliptin in humans显示文摘VINCENT SH REED JR BERGMAN AJ 2007Drug Metab Dispos2007,35,4:1
17Pharmacokinetic andpharmacodynamic properties of multiple oral doses of sitagliptin,adipeptidyl peptidase-IV inhibitor:a double-blind,randomized,placebo-controlled study in healthy male volunteers显示文摘Bergman AJ Stevens C Zhou Y 2006Clin Ther2006,28,1:1
18Aneurysmal bone cyst: Fine-needle aspiration findings in 23 patients with clinical and radiologic correlation显示文摘CREAGER AJ MADDEN CR BERGMAN S 2007Am J Clin Pathol2007,128,5:1
19Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin,a dipeptidyl peptidase-IV inhibitor:a double-blind,randomized,placebo-controlled study in healthy male volunteers显示文摘Bergman AJ Stevens C Zhou Y 0,,:1
20Pharmacokinetic and pharmacodynamics properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo- controlled study in healthy male volunteers显示文摘Bergman AJ Stevens C Zhou Y 2006Clin Pharmacol Ther2006,28,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费